Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Su, Rui  [Clear All Filters]
Journal Article
Zhang B, Zhao D, Chen F, Frankhouser D, Wang H, Pathak KV, Dong L, Torres A, Garcia-Mansfield K, Zhang Y, et al. Acquired miR-142 deficit in leukemic stem cells suffices to drive chronic myeloid leukemia into blast crisis. Nat Commun. 2023;14(1):5325.
Su R, Gong J-N, Chen M-T, Song L, Shen C, Zhang X-H, Yin X-L, Ning H-M, Liu B, Wang F, et al. c-Myc suppresses miR-451⊣YWTAZ/AKT axis via recruiting HDAC3 in acute myeloid leukemia. Oncotarget. 2016.
Su R, Cao S, Ma J, Liu Y, Liu X, Zheng J, Chen J, Liu L, Cai H, Li Z, et al. Correction: Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122. Mol Cancer. 2022;21(1):202.
Smela MDPierson, Kramme CC, Fortuna PRJ, Adams JL, Su R, Dong E, Kobayashi M, Brixi G, Kavirayuni VSrikar, Tysinger E, et al. Directed differentiation of human iPSCs to functional ovarian granulosa-like cells via transcription factor overexpression. Elife. 2023;12.
Lee C-L, Chen Z, Zhang Q, Guo Y, W Y Ng V, Zhang B, Bai K, Ruan D, S Y Kan A, Cheung K-W, et al. Dysregulation of the CD147 complex confers defective placental development: A pathogenesis of early-onset preeclampsia. Clin Transl Med. 2022;12(6):e826.
He N, Su R, Wang Z, Zhang Y, Li J. Exploring differentially expressed genes between anagen and telogen secondary hair follicle stem cells from the Cashmere goat (Capra hircus) by RNA-Seq. PLoS One. 2020;15(4):e0231376.
Cao K, Du Y, Bao X, Han M, Su R, Pang J, Liu S, Shi Z, Yan F, Feng S. Glutathione-Bioimprinted Nanoparticles Targeting of N6-methyladenosine FTO Demethylase as a Strategy against Leukemic Stem Cells. Small. 2022:e2106558.
Zhang X, Ma Y, Yu J, Su R, Wang X. Internal m6A and m7G RNA modifications in hematopoietic system and acute myeloid leukemia. Chin Med J (Engl). 2024.
Li Z, Chen P, Su R, Hu C, Li Y, Elkahloun AG, Zuo Z, Gurbuxani S, Arnovitz S, Weng H, et al. PBX3 and MEIS1 cooperate in hematopoietic cells to drive acute myeloid leukemias characterized by a core transcriptome of the MLL-rearranged disease. Cancer Res. 2016.
Chen Z, Zhou K, Xue J, Small A, Xiao G, Nguyen LXuan Truon, Zhang Z, Prince E, Weng H, Huang H, et al. Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemia. Sci Transl Med. 2023;15(689):eabq8513.
Zhao Z, Qing Y, Dong L, Han L, Wu D, Li Y, Li W, Xue J, Zhou K, Sun M, et al. QKI shuttles internal mG-modified transcripts into stress granules and modulates mRNA metabolism. Cell. 2023.
Qing Y, Dong L, Gao L, Li C, Li Y, Han L, Prince E, Tan B, Deng X, Wetzel C, et al. R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/mA/PFKP/LDHB axis. Mol Cell. 2021.
Shen C, Sheng Y, Zhu AC, Robinson S, Jiang X, Dong L, Chen H, Su R, Yin Z, Li W, et al. RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia. Cell Stem Cell. 2020.
Yin Z, Su R, Ge L, Wang X, Yang J, Huang G, Li C, Liu Y, Zhang K, Deng L, et al. Single-cell resolution reveals RalA GTPase expanding hematopoietic stem cells and facilitating of BCR-ABL1-driven leukemogenesis in a CRISPR/Cas9 gene editing mouse model. Int J Biol Sci. 2023;19(4):1211-1227.
Huang G, Yin Z, Wang X, Wen Z, Su R, Li C, Liu Y, Yang J, Hu HY, Nie H, et al. System analysis of Huang-Lian-Jie-Du-Tang and their key active ingredients for overcoming CML resistance by suppression of leukemia stem cells. Phytomedicine. 2023;117:154918.
Su R, Dong L, Li Y, Gao M, Han L, Wunderlich M, Deng X, Li H, Huang Y, Gao L, et al. Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion. Cancer Cell. 2020.
Su R, Li C, Wang X, Li Z, Wen Z, Yin Z, Huang G, Liu Y, Yang J, Hu HY, et al. targeting miR-181a mimic and saRNA overcome imatinib resistance in BCR-ABL1-independent chronic myeloid leukemia by suppressing leukemia stem cell regeneration. Mol Ther Nucleic Acids. 2023;32:729-742.
Dong H, He X, Zhang L, Chen W, Lin Y-C, Liu S-B, Wang H, Nguyen LXuan Truon, Li M, Zhu Y, et al. Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity. Nat Cancer. 2024.